OC-0229: Focal salvage HDR brachytherapy for prostate cancer recurrence after primary external radiotherapy von Djupvik, L, Tafjord, G, Russnes, K.M, Gustafsson, H, Lilleby, W, Hellebust, T.P

Volltext

89P Comprehensive genomic profiling of circulating tumor DNA for treatment recommendation: A sub-project of the IMPRESS-Norway trial von Dyvik, I., Fagereng, L., Lien, T., Nygaard, V., Silwal-Pandit, L., Noone, J.C., Wennerström, A.B., Skjulsvik, A.J., Ersland, K.M., Guren, T.K.K., Puco, K., Brabrand, S., Blix, E.S., Flobak, A., Haug, A., Johansson, K.A.M., Smeland, S., Tasken, K., Helland, A., Russnes, H.E.G.

Volltext

213P Unlocking cancer treatment opportunities by population-based advanced diagnostics in Norway von Russnes, H.E.G., Nilsen, H.L., Jebens, M., Janssen, E., Wold, R.M., Meza-Zepeda, L.A., Hovig, E., Lien, T., Nygaard, V., Niehusmann, P., Ersland, K.M., Forthun, R., Haugland, H.K., Wennerström, A.B., Lüders, T., Randen, U., Dai, H.Y., Granlund, A.V.B., Skjulsvik, A.J., Hovland, R.

Volltext